Loading...

Decreasing Trend in Mortality of Chronic Myelogenous Leukemia Patients After Introduction of Imatinib in Japan and the U.S.

PURPOSE. Although the impact of imatinib in improving survival outcomes in chronic myelogenous leukemia (CML) patients has been widely reported, its impact on mortality from CML has not been evaluated. A survival benefit demonstrated in clinical trials does not simply translate to a decrease in mort...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Chihara, Dai, Ito, Hidemi, Matsuda, Tomohiro, Katanoda, Kota, Shibata, Akiko, Saika, Kumiko, Sobue, Tomotaka, Matsuo, Keitaro
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528387/
https://ncbi.nlm.nih.gov/pubmed/22971523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0197
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!